BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Muhammad N, Bhattacharya S, Steele R, Phillips N, Ray RB. Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 2017;23:3120-8. [PMID: 27965308 DOI: 10.1158/1078-0432.CCR-16-2811] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Alekseenko L, Shilina M, Kozhukharova I, Lyublinskaya O, Fridlyanskaya I, Nikolsky N, Grinchuk T. Impact of Polyallylamine Hydrochloride on Gene Expression and Karyotypic Stability of Multidrug Resistant Transformed Cells. Cells 2020;9:E2332. [PMID: 33096691 DOI: 10.3390/cells9102332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 D'Arcangelo D, Tinaburri L, Dellambra E. The Role of p16INK4a Pathway in Human Epidermal Stem Cell Self-Renewal, Aging and Cancer. Int J Mol Sci 2017;18:E1591. [PMID: 28737694 DOI: 10.3390/ijms18071591] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
3 Yang PJ, Hsieh MJ, Lee CI, Yen CH, Wang HL, Chiang WL, Liu TC, Tsao TC, Lee CY, Yang SF. Impact of Aurora Kinase A Polymorphism and Epithelial Growth Factor Receptor Mutations on the Clinicopathological Characteristics of Lung Adenocarcinoma. Int J Environ Res Public Health 2020;17:E7350. [PMID: 33050100 DOI: 10.3390/ijerph17197350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Wang P, Zhang Y, Wang W, Jiang H. Upregulation of FTX expression is associated with a poor prognosis and contributes to the progression of thyroid cancer. Oncol Lett 2021;22:672. [PMID: 34345297 DOI: 10.3892/ol.2021.12933] [Reference Citation Analysis]
5 Brennan A, Leech JT, Kad NM, Mason JM. Selective antagonism of cJun for cancer therapy. J Exp Clin Cancer Res 2020;39:184. [PMID: 32917236 DOI: 10.1186/s13046-020-01686-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wu Q, Zhang B, Li B, Cao X, Chen X, Xue Q. PTBP3 promotes migration of non-small cell lung cancer through regulating E-cadherin in EMT signaling pathway. Cancer Cell Int 2020;20:172. [PMID: 32477006 DOI: 10.1186/s12935-020-01240-9] [Reference Citation Analysis]
7 Nandy D, Rajam SM, Dutta D. A three layered histone epigenetics in breast cancer metastasis. Cell Biosci 2020;10:52. [PMID: 32257110 DOI: 10.1186/s13578-020-00415-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Dong P, Xiong Y, Hanley SJB, Yue J, Watari H. Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation. J Exp Clin Cancer Res 2017;36:150. [PMID: 29073938 DOI: 10.1186/s13046-017-0617-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
9 Mohan A, Raj R R, Mohan G, K P P, Thomas Maliekal T. Reporters of Cancer Stem Cells as a Tool for Drug Discovery. Front Oncol 2021;11:669250. [PMID: 33968778 DOI: 10.3389/fonc.2021.669250] [Reference Citation Analysis]
10 Chen Y, Zhao H, Liang W, Jiang E, Zhou X, Shao Z, Liu K, Shang Z. Autophagy regulates the cancer stem cell phenotype of head and neck squamous cell carcinoma through the noncanonical FOXO3/SOX2 axis. Oncogene 2021. [PMID: 34795388 DOI: 10.1038/s41388-021-02115-7] [Reference Citation Analysis]
11 Bolan PO, Zviran A, Brenan L, Schiffman JS, Dusaj N, Goodale A, Piccioni F, Johannessen CM, Landau DA. Genotype-Fitness Maps of EGFR-Mutant Lung Adenocarcinoma Chart the Evolutionary Landscape of Resistance for Combination Therapy Optimization. Cell Syst 2020;10:52-65.e7. [PMID: 31668800 DOI: 10.1016/j.cels.2019.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
12 Seliger B, Massa C, Yang B, Bethmann D, Kappler M, Eckert AW, Wickenhauser C. Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma. Int J Mol Sci 2020;21:E7032. [PMID: 32987799 DOI: 10.3390/ijms21197032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Luo Q, Wu X, Chang W, Zhao P, Nan Y, Zhu X, Katz JP, Su D, Liu Z. ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness. Cell Death Differ 2020;27:1981-97. [PMID: 31831874 DOI: 10.1038/s41418-019-0475-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
14 Liang X, Xu C, Cao X, Wang W. Isovitexin Suppresses Cancer Stemness Property And Induces Apoptosis Of Osteosarcoma Cells By Disruption Of The DNMT1/miR-34a/Bcl-2 Axis. Cancer Manag Res 2019;11:8923-36. [PMID: 31686915 DOI: 10.2147/CMAR.S222708] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
15 Zhou X, Zhai Y, Liu C, Yang G, Guo J, Li G, Sun C, Qi X, Li X, Guan F. Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5β1 interaction and Akt signaling pathway. Cell Commun Signal 2020;18:44. [PMID: 32164705 DOI: 10.1186/s12964-019-0500-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Feng D, Yan K, Liang H, Liang J, Wang W, Yu H, Zhou Y, Zhao W, Dong Z, Ling B. CBP-mediated Wnt3a/β-catenin signaling promotes cervical oncogenesis initiated by Piwil2. Neoplasia 2021;23:1-11. [PMID: 33190089 DOI: 10.1016/j.neo.2020.10.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Gao F, Zhou L, Li M, Liu W, Yang S, Li W. Inhibition of ERKs/Akt-Mediated c-Fos Expression Is Required for Piperlongumine-Induced Cyclin D1 Downregulation and Tumor Suppression in Colorectal Cancer Cells. Onco Targets Ther 2020;13:5591-603. [PMID: 32606774 DOI: 10.2147/OTT.S251295] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Zhang K, Ying H, Zhao R, Chen Y, Deng Q. Capilliposide from Lysimachia capillipes promotes terminal differentiations and reverses paclitaxel resistance in A2780T cells of human ovarian cancer by regulating Fos/Jun pathway. Chinese Herbal Medicines 2021. [DOI: 10.1016/j.chmed.2021.09.009] [Reference Citation Analysis]
19 Chugh A, Purohit P, Vishnoi JR, Kaur A, Modi A, Mishra S, Sharma P, Rodha MS, Pareek P, Bhattacharya S, Gigi PG. Correlation of hsa miR-101-5p and hsa miR-155-3p Expression With c-Fos in Patients of Oral Submucous Fibrosis (OSMF) and Oral Squamous Cell Carcinoma (OSCC). J Maxillofac Oral Surg . [DOI: 10.1007/s12663-021-01668-0] [Reference Citation Analysis]
20 Dolgova EV, Petrova DD, Proskurina AS, Ritter GS, Kisaretova PE, Potter EA, Efremov YR, Bayborodin SI, Karamysheva TV, Romanenko MV, Netesov SV, Taranov OS, Ostanin AA, Chernykh ER, Bogachev SS. Identification of the xenograft and its ascendant sphere-forming cell line as belonging to EBV-induced lymphoma, and characterization of the status of sphere-forming cells. Cancer Cell Int 2019;19:120. [PMID: 31080361 DOI: 10.1186/s12935-019-0842-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Shen Z, Zhang C, Qu L, Lu C, Xiao M, Ni R, Liu J. MKP-4 suppresses hepatocarcinogenesis by targeting ERK1/2 pathway. Cancer Cell Int 2019;19:61. [PMID: 30923463 DOI: 10.1186/s12935-019-0776-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
22 Lei B, Wang D, Zhang M, Deng Y, Jiang H, Li Y. miR-615-3p promotes the epithelial-mesenchymal transition and metastasis of breast cancer by targeting PICK1/TGFBRI axis. J Exp Clin Cancer Res. 2020;39:71. [PMID: 32336285 DOI: 10.1186/s13046-020-01571-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
23 Minopoli M, Botti G, Gigantino V, Ragone C, Sarno S, Motti ML, Scognamiglio G, Greggi S, Scaffa C, Roca MS, Stoppelli MP, Ciliberto G, Losito NS, Carriero MV. Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion. J Exp Clin Cancer Res 2019;38:459. [PMID: 31703596 DOI: 10.1186/s13046-019-1465-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
24 Aytatli A, Barlak N, Sanli F, Caglar HO, Gundogdu B, Tatar A, Ittmann M, Karatas OF. AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer. Cell Oncol (Dordr) 2021. [PMID: 34837170 DOI: 10.1007/s13402-021-00645-6] [Reference Citation Analysis]
25 Abdel-Megeed RM, Hamed AR, Matloub AA, Kadry MO, Abdel-Hamid AZ. Regulation of apoptotic and inflammatory signaling pathways in hepatocellular carcinoma via Caesalpinia gilliesii galactomannan. Mol Cell Biochem 2019;451:173-84. [PMID: 30030776 DOI: 10.1007/s11010-018-3404-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
26 Dong C, Zhang J, Fang S, Liu F. IGFBP5 increases cell invasion and inhibits cell proliferation by EMT and Akt signaling pathway in Glioblastoma multiforme cells. Cell Div 2020;15:4. [PMID: 32127912 DOI: 10.1186/s13008-020-00061-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
27 Kurago Z, Loveless J. Microbial Colonization and Inflammation as Potential Contributors to the Lack of Therapeutic Success in Oral Squamous Cell Carcinoma. Front Oral Health 2021;2:739499. [PMID: 35048056 DOI: 10.3389/froh.2021.739499] [Reference Citation Analysis]
28 Pan M, Schinke H, Luxenburger E, Kranz G, Shakhtour J, Libl D, Huang Y, Gaber A, Pavšič M, Lenarčič B, Kitz J, Jakob M, Schwenk-Zieger S, Canis M, Hess J, Unger K, Baumeister P, Gires O. EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers. PLoS Biol 2018;16:e2006624. [PMID: 30261040 DOI: 10.1371/journal.pbio.2006624] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
29 Maklad A, Sedeeq M, Milevskiy MJG, Azimi I. Calcium Signalling in Medulloblastoma: An In Silico Analysis of the Expression of Calcium Regulating Genes in Patient Samples. Genes (Basel) 2021;12:1329. [PMID: 34573310 DOI: 10.3390/genes12091329] [Reference Citation Analysis]
30 Zhang R, Li X, Liu Z, Wang Y, Zhang H, Xu H. EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress. Cancer Cell Int 2020;20:175. [PMID: 32477007 DOI: 10.1186/s12935-020-01260-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Chen Y, Liang W, Liu K, Shang Z. FOXD1 promotes EMT and cell stemness of oral squamous cell carcinoma by transcriptional activation of SNAI2. Cell Biosci 2021;11:154. [PMID: 34348789 DOI: 10.1186/s13578-021-00671-9] [Reference Citation Analysis]
32 Liu S, Yao X, Zhang D, Sheng J, Wen X, Wang Q, Chen G, Li Z, Du Z, Zhang X. Analysis of Transcription Factor-Related Regulatory Networks Based on Bioinformatics Analysis and Validation in Hepatocellular Carcinoma. Biomed Res Int. 2018;2018:1431396. [PMID: 30228980 DOI: 10.1155/2018/1431396] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
33 Naz H, Tarique M, Suhail M, Shankar H, Muhammad N, Usmani D, Ashraf M, Zughaibi TA. Calcium-/Calmodulin-Dependent Protein Kinase IV (CAMKIV): A Multifunctional Enzyme and Its Role in Various Cancer: An Update. Curr Mol Bio Rep 2020;6:139-47. [DOI: 10.1007/s40610-020-00138-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Sun J. RASSF-1A modulates proliferation-mediated oral squamous cell carcinoma progression. Cancer Cell Int 2019;19:213. [PMID: 31423110 DOI: 10.1186/s12935-019-0932-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Baj J, Korona-Głowniak I, Forma A, Maani A, Sitarz E, Rahnama-Hezavah M, Radzikowska E, Portincasa P. Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer. Cells 2020;9:E1055. [PMID: 32340207 DOI: 10.3390/cells9041055] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
36 Hao Y, Zhu L, Yan L, Liu J, Liu D, Gao N, Tan M, Gao S, Lin B. c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer. Oncol Rep 2017;38:3355-66. [PMID: 29130097 DOI: 10.3892/or.2017.6052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
37 Habib I, Anjum F, Mohammad T, Sulaimani MN, Shafie A, Almehmadi M, Yadav DK, Sohal SS, Hassan MI. Differential gene expression and network analysis in head and neck squamous cell carcinoma. Mol Cell Biochem 2022. [PMID: 35142951 DOI: 10.1007/s11010-022-04379-3] [Reference Citation Analysis]
38 Huang C, Chen R, Zheng F, Tang Y, Wang X, Chen Z, Lai X. Inhibitory role of ATF3 in gastric cancer progression through regulating cell EMT and stemness. Cancer Cell Int 2021;21:127. [PMID: 33608016 DOI: 10.1186/s12935-021-01828-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
39 Lee JS, Kim YA, Jang YJ, Oh Y, Byun S. Dihydrocapsaicin Inhibits Epithelial Cell Transformation through Targeting Amino Acid Signaling and c-Fos Expression. Nutrients 2019;11:E1269. [PMID: 31167465 DOI: 10.3390/nu11061269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Baumeister P, Zhou J, Canis M, Gires O. Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas. Cancers (Basel) 2021;13:5355. [PMID: 34771518 DOI: 10.3390/cancers13215355] [Reference Citation Analysis]
41 Son SW, Lee HY, Moeng S, Kuh HJ, Choi SY, Park JK. Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals. Molecules 2020;25:E4701. [PMID: 33066509 DOI: 10.3390/molecules25204701] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
42 Zhao C, Ling X, Xia Y, Yan B, Guan Q. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis. Cancer Cell Int 2021;21:441. [PMID: 34419065 DOI: 10.1186/s12935-021-02113-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
43 Chen Y, Shao X, Cao J, Zhu H, Yang B, He Q, Ying M. Phosphorylation regulates cullin-based ubiquitination in tumorigenesis. Acta Pharm Sin B 2021;11:309-21. [PMID: 33643814 DOI: 10.1016/j.apsb.2020.09.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Qu X, Yan X, Kong C, Zhu Y, Li H, Pan D, Zhang X, Liu Y, Yin F, Qin H. c-Myb promotes growth and metastasis of colorectal cancer through c-fos-induced epithelial-mesenchymal transition. Cancer Sci 2019;110:3183-96. [PMID: 31338937 DOI: 10.1111/cas.14141] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
45 Ma J, Zhou C, Chen X. miR-636 inhibits EMT, cell proliferation and cell cycle of ovarian cancer by directly targeting transcription factor Gli2 involved in Hedgehog pathway. Cancer Cell Int 2021;21:64. [PMID: 33472614 DOI: 10.1186/s12935-020-01725-7] [Reference Citation Analysis]
46 Santos J, Pallarès I, Iglesias V, Ventura S. Cryptic amyloidogenic regions in intrinsically disordered proteins: Function and disease association. Comput Struct Biotechnol J 2021;19:4192-206. [PMID: 34527192 DOI: 10.1016/j.csbj.2021.07.019] [Reference Citation Analysis]
47 Wang Y, Wan GH, Wu YM, Wang HS, Wang HF, Zhang G, Lu LL, Li ZQ, Chan KY, Zhou Y, Cai SH, Qi YF, Du J. AP-1 confers resistance to anti-cancer therapy by activating XIAP. Oncotarget 2018;9:14124-37. [PMID: 29581832 DOI: 10.18632/oncotarget.23897] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]